Navigation Links
iPierian to Collaborate With Johns Hopkins University on $3.7 Million NIH Grand Opportunities Grant
Date:10/21/2009

generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways.

About iPierian

iPierian is a South San Francisco-based biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient cells. iPierian is backed by Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute of Cardiovascular Disease and Dr. Deepak Srivastava, the institute's director. iPierian plans to enhance its partnership efforts to further expand into metabolic diseases. Earlier this year, the company announced a formal collaboration with the laboratory of Dr. Shinya Yamanaka of Kyoto University to develop and improve methods of deriving iPS cell lines in order to advance iPS cell technology.

Because iPS cells are believed to be able to grow indefinitely in culture and to differentiate into many cell types, iPS cells have great potential for disease research, preclinical drug testing and cell-based therapy. iPierian's approach places the patient at the forefront of the drug discovery process in order to reduce drug development time and increase the probability of success for drug candidates. iPierian plans to use precise human disease models to find new molecular targets and develop proprietary therapeutic small molecule or biologic drugs for its own pipeline to treat specific diseases.

SOURCE iPierian, Inc.


'/>"/>
SOURCE iPierian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
2. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
3. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
4. Rice, Nanyang Tech collaborate on sustainable nanoelectronics
5. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
6. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
7. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
8. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
9. New Pharmacogenomic Approach: 454 Life Sciences and Perlegen to Collaborate in Drug Response Sequencing Study
10. Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Francisco, California (PRWEB) October 01, 2014 ... from the National Science Foundation to expand their bioCAD/CAM ... to build and modify DNA. The Small Business Innovation ... commercialize the “j5” technology under exclusive license from the ... Joint BioEnergy Institute , an LBNL laboratory that ...
(Date:10/1/2014)... , October 1, 2014 ... software invited to engage around the theme, ,Commercial Opportunities ...   Elsevier , a ... and services, will host a gathering of some of ... and trends impacting healthcare today and in the future. ...
(Date:9/30/2014)... news release is available in German . ... the Technische Universitt Mnchen (TUM) have demonstrated a new ... experiments show that future computer chips could be based ... As the main enabling technology of the semiconductor industry ... limits, the TUM researchers and collaborators at the University ...
(Date:9/30/2014)... , Sept. 30, 2014 Report Details ... with highest potential revenues Do you want to ... gives you revenue predictions for those biological drugs ... therapies you find financial data, R&D trends, opportunities ... get sales forecasts to 2024 at overall world ...
Breaking Biology Technology:TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5
... Biotechnology,International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or ... and animals, located in the,People,s Republic of China, ... to be the,Company,s new chief financial officer effective ... who served as the Company,s principal financial,officer. ...
... LONDON, April 1 The ,2008 European Telemedicine Systems ... is presented to SHL Telemedicine Ltd. in recognition of ... This full 12 lead ECG personal digital cellular transmitter ... (GPRS) or public switched telephone network (PSTN) to transmit ...
... Based on its recent analysis of the elastic nonwovens market, ... North American Frost & Sullivan Technology Leadership of the Year ... field of styrenic block copolymers (SBCs). Already established as an ... new family of SBCs, the MD6705, G1643, and MD6717 grades ...
Cached Biology Technology:Yongye Biotechnology Appoints New Chief Financial Officer 2Yongye Biotechnology Appoints New Chief Financial Officer 3Frost & Sullivan Applauds SHL Telemedicine for Excellence in Product Innovation 2Frost & Sullivan Applauds SHL Telemedicine for Excellence in Product Innovation 3Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 2Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 3Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 4Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 5
(Date:10/1/2014)... take a healthy salad up a level by growing ... in leafy greens. , "In the long run, one ... the salad or making a pill from the plant ... at Case Western Reserve School of Medicine and leader ... cancer organization is funding the research with a three-year, ...
(Date:9/30/2014)... of moorland burning is published today in the first ... of relieving tensions on both sides of the grouse ... Moorland Burning on the Ecohydrology of River basins) project ... practised predominantly to support red grouse populations for gun ... chemistry and physical properties, river water chemistry and river ...
(Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Grouse moor burning causes widespread environmental changes 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2
... In a one-two punch, a familiar diabetes drug reduced ... chemotherapy alone, apparently by targeting cancer stem cells, report ... online Cancer Research . "We have found ... author Kevin Struhl, the David Wesley Gaiser professor of ...
... NY How much difference can a tenth of a ... work, an improvement in resolution of that miniscule amount can ... how they interact. Case in point: New, improved-resolution views ... of Energy,s Brookhaven National Laboratory provide not just a structure ...
... postage stamp-sized sensor that can sniff out some known poisonous ... colors. Support for the development and application of ... Health Sciences, part of the National Institutes of Health. The ... Nature Chemistry and exemplifies the types of sensors that ...
Cached Biology News:Diabetes drug kills cancer stem cells in combination treatment in mice 2Diabetes drug kills cancer stem cells in combination treatment in mice 3High-res view of zinc transport protein 2High-res view of zinc transport protein 3Electronic nose sniffs out toxins 2
...
... Dr. P Set from different Cynomolgus ... More organs maybe available upon request. ... items from the whole set, and ... price. All Dr. P Set ...
...
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: